All patients
subjects at risk
hydroxychloroquine in COVID 19 outpatients - Summary of results Outcome TE 95% CI n k I2 ROB Pub. bias deathsdetailed results COPE – Coalition V, 2022 1.56 [0.39; 6.24]
COVID-PEP Severity (Skipper), 2020 1.01 [0.06; 16.28]
1.43 [0.41 ; 4.95 ] COPE – Coalition V, 2022, COVID-PEP Severity (Skipper), 2020 2 0% 1,860 moderate not evaluable clinical improvementdetailed results COVID-PEP Severity (Skipper), 2020 1.36 [0.87; 2.11]
1.36 [0.87 ; 2.11 ] COVID-PEP Severity (Skipper), 2020 1 0% 395 NA not evaluable clinical improvement (14-day)detailed results COVID-PEP Severity (Skipper), 2020 1.36 [0.87; 2.11]
1.36 [0.87 ; 2.11 ] COVID-PEP Severity (Skipper), 2020 1 0% 395 NA not evaluable hospitalizationdetailed results COPE – Coalition V, 2022 0.77 [0.52; 1.13]
0.77 [0.52 ; 1.13 ] COPE – Coalition V, 2022 1 0% 1,372 NA not evaluable mechanical ventilationdetailed results COPE – Coalition V, 2022 1.32 [0.46; 3.79]
1.32 [0.46 ; 3.79 ] COPE – Coalition V, 2022 1 0% 1,369 NA not evaluable viral clearance detailed results Q-PROTECT -HCQ alone, 2020 0.88 [0.53; 1.45]
0.88 [0.53 ; 1.45 ] Q-PROTECT -HCQ alone, 2020 1 0% 289 NA not evaluable viral clearance by day 14detailed results Q-PROTECT -HCQ alone, 2020 0.88 [0.53; 1.45]
0.88 [0.53 ; 1.45 ] Q-PROTECT -HCQ alone, 2020 1 0% 289 NA not evaluable viral clearance by day 7detailed results Q-PROTECT -HCQ alone, 2020 1.05 [0.53; 2.09]
1.05 [0.53 ; 2.09 ] Q-PROTECT -HCQ alone, 2020 1 0% 296 NA not evaluable ICU admissiondetailed results COPE – Coalition V, 2022 0.84 [0.43; 1.63]
0.84 [0.43 ; 1.63 ] COPE – Coalition V, 2022 1 0% 1,369 NA not evaluable adverse eventsdetailed results COVID-PEP Severity (Skipper), 2020 1.00 [0.02; 50.40]
1.00 [0.02 ; 50.40 ] COVID-PEP Severity (Skipper), 2020 1 0% 423 NA not evaluable 0.5 2.0 1.0 relative treatment effect www.metaEvidence.org 2024-05-07 18:10 +02:00
TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers);
k: number of studies; n: total number of patients;
ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
pathologies: 97
- treatments: 657,832
- roots T: 290
